Akso Health (AHG) Liabilities and Shareholders Equity (2017 - 2025)

Akso Health has reported Liabilities and Shareholders Equity for 9 years, with the latest figure at $212.0 million in Q3 2025.

• For the quarter ending Q3 2025, Liabilities and Shareholders Equity changed 0.43% year-over-year to $212.0 million; the trailing twelve-month figure through Sep 2025 stood at $782.0 million (up 99.32% YoY), and the FY2025 full-year result was $215.0 million, up 51.36% from the prior year.
• Liabilities and Shareholders Equity for Q3 2025 stood at $212.0 million, down from $215.0 million in the prior quarter.
• The five-year high for Liabilities and Shareholders Equity was $215.0 million in Q1 2025, with the low at $32.52 in Q3 2021.
• Historically, Liabilities and Shareholders Equity has averaged $93.5 million across 5 years, with a median of $47.2 million in 2021.
• Annual changes were most pronounced in 2021 — Liabilities and Shareholders Equity plunged 100.0% — and 2022, when it jumped 64281681.64%.
• Akso Health's Liabilities and Shareholders Equity stood at $32.52 in 2021, then soared by 64281681.64% to $20.9 million in 2022, then fell by 19.26% to $16.9 million in 2023, then jumped by 1161.51% to $212.9 million in 2024, then decreased by 0.43% to $212.0 million in 2025.
• The last three Liabilities and Shareholders Equity figures came in at $212.0 million (Q3 2025), $215.0 million (Q1 2025), and $212.9 million (Q3 2024), per Business Quant data.